Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LSS | P48449 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4197565 | 1.00 | EPHX1 (0.42) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL13086429 | 1.00 | EPHX1 (0.42) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL11777705 | 1.00 | EPHX1 (0.42) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL27735675 | 1.00 | EPHX1 (0.42) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL11775836 | 1.00 | EPHX1 (0.42) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL11779058 | 1.00 | EPHX1 (0.42) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL11777444 | 0.98 | CYP1A2 (0.41) | EPHX1MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL11721997 | 0.92 | CYP1A2 (0.45) | MEN1HTTKMT2ACYP1A2PKM | |
| Formic Acid SCHEMBL30917797 | 0.88 | PKM (0.41) | MEN1HTTKMT2ALSSCYP1A2 | |
| SCHEMBL9643503 | 0.88 | CYP1A2 (0.48) | EPHX1MEN1HTTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220204423-A1 | CASHEW NUT SHELL LIQUID BASED SUBSTITUTED CYCLOHEXENE DERIVATIVES AND USES THEREOF | CARDOLITE CORPORATION | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204423-A1 | CASHEW NUT SHELL LIQUID BASED SUBSTITUTED CYCLOHEXENE DERIVATIVES AND USES THEREOF | HTR3D, DNER, TAS1R3 | EPHX1 630/4885MEN1 4439/4885HTT 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.